Poll: How comfortable are you with including biosimilars in your treatment plans?

Poll

Vote in our most recent poll!

How comfortable are you with including biosimilars in your treatment plans?

A. Very excited to begin embracing biosimilars
B. Feeling comfortable exploring biosimilar options, though cautiously
C. Still hesitant, I need to learn more about biosimilars
D. With the knowledge of biosimilars I have, I am not comfortable including this in my treatment plans

RELATED: Introduction to biosimilars for AMD

Recent Videos
Jeffry Gerson, OD, FAAO, chats with Optometry Times about his talks about retina conditions at Vision Expo West
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
Mohammad Rafieetary, OD, FAAO
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
R Tracy Williams, OD, FAAO with Optometry Times
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
Related Content
Blue light illuminates empty desk with laptop Image credit: AdobeStock/Maria Mikhaylichenko/AI

Understanding blue light: Making sense of the spectrum

Thomas A. Wong, OD, FAAO, FNAP;Karl Citek, OD, PhD, FAAO
November 14th 2024
Article
How to implement a custom contact lens fitting model into your practice

How to implement a custom contact lens fitting model into your practice

Luis Rojas, OD;Emily Kaiser Maharjan, Assistant Managing Editor
September 25th 2023
Podcast
Doctor sitting at desk with medical eye figure Image credit: AdobeStock/JoPanuwatD

Ocular Therapeutix accelerates timelines for SOL-1 Phase 3 trial of Axpaxli for wet AMD

Jordana Joy, Associate Editor
October 18th 2024
Article
In this week's episode, Alison Bozung, OD, speaks on classifying "ocular emergencies," differentiating between urgencies and emergencies from a patient's perspective, and much more!

Open your eyes: ocular emergencies

Kerry Gelb, OD
January 17th 2022
Podcast
Iris freckles: Potential biomarker for AMD

Iris freckles: Potential biomarker for AMD

Lynda Charters
October 2nd 2024
Article
preclinical data for AMD trial - Image credit: Adobe Stock/©Cavan

Stealth BioTherapeutics presents preclinical data on bevemipretide's retinal delivery in AMD models

Martin David Harp, Associate Editor, Ophthalmology Times
September 25th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.